康寧傑瑞製藥－Ｂ(09966.HK)公布2023年止年度業績，收入錄得2.19億人民幣(下同)，按年增加31.1%。虧損由上年度3.26億元，收窄至2.11億元，每股虧損22分。不派末期息。
《公司業績》康寧傑瑞製藥(09966.HK)全年虧損收窄至2.11億人民幣
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.